Zions Bancorporation Company Profile (NASDAQ:ZION)

Zions Bancorporation trades on the NASDAQ under the ticker symbol "ZION."

Zions Bancorporation declared a quarterly dividend on Thursday, July 20th. Stockholders of record on Thursday, August 17th will be paid a dividend of $0.12 per share on Thursday, August 24th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Tuesday, August 15th. This is a positive change from Zions Bancorporation's previous quarterly dividend of $0.08. View Zions Bancorporation's Dividend History.

Zions Bancorporation declared that its board has approved a share buyback program on Thursday, June 29th 2017, which allows the company to repurchase $465,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 5.3% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its shares are undervalued.

Zions Bancorporation (NASDAQ:ZION) issued its earnings results on Tuesday, July, 25th. The company reported $0.73 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.62 by $0.11. The business earned $660 million during the quarter, compared to analyst estimates of $640.34 million. Zions Bancorporation had a net margin of 21.97% and a return on equity of 8.14%. During the same quarter in the prior year, the company earned $0.44 EPS. View Zions Bancorporation's Earnings History.

Zions Bancorporation is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for Zions Bancorporation.

22 brokerages have issued 12-month price targets for Zions Bancorporation's shares. Their predictions range from $36.00 to $56.00. On average, they anticipate Zions Bancorporation's stock price to reach $45.15 in the next twelve months. View Analyst Ratings for Zions Bancorporation.

Here are some recent quotes from research analysts about Zions Bancorporation stock:

• 1. According to Zacks Investment Research, "Zions’ shares have outperformed the Zacks categorized Banks-West industry over the last six months. The company has been witnessing consistent growth in loans and deposits along with easing margin pressure, indicating improvement in revenues in the quarters ahead. Moreover, once the Financial Choice Act gets implemented, the company is likely to increase lending activities, which should lead to further improvement in top-line. Also, Zions’ initiatives to control expenses have been successful and are expected to aid bottom line growth in the quarters ahead. Moreover, Fed’s approval to the 2017 capital plan remains encouraging. However, a risky loan portfolio along with concentration risk could hurt the company’s financials, going forward." (7/13/2017)
• 2. FIG Partners analysts commented, "Following release of the company's 4Q-16 results, we are maintaining our rating on ZION-Zions Bancorp at 'Outperform' and lowering our Price Target to $49.00 (from $51.00), as well as adjusting our EPS estimates to $0.52 for 1Q-17 (unchanged), $2.33 for 2017 (form $2.38) and $2.81 for 2018 (from $2.94). Our Price Target is equivalent to 21x forward EPS ($2.33) and 161% of tangible book value ($30.39)." (1/24/2017)
• 3. Jefferies Group LLC analysts commented, "NII and credit beat in 4Q, but expenses and fees missed. The outlook for '17 was favorable for credit (improving energy NCOs), but unfavorable for expenses, with tech. spend a continued headwind. Full appreciation of higher shares (warrants related) likely pressures some Street ests. lower. We increased our '17 EPS est. by $0.05 to $2.45 and held '18 at $2.85." (1/24/2017)

Zions Bancorporation saw a increase in short interest during the month of July. As of July 14th, there was short interest totalling 18,200,770 shares, an increase of 7.2% from the June 30th total of 16,974,554 shares. Based on an average daily volume of 2,348,707 shares, the short-interest ratio is currently 7.7 days. Currently, 9.1% of the company's shares are short sold.

Some companies that are related to Zions Bancorporation include Citizens Financial Group (CFG), First Republic Bank (FRC), Grupo Financiero Santander Mexico S.A. B. de C.V. (BSMX), BOK Financial Corporation (BOKF), Western Alliance Bancorporation (WAL), Pinnacle Financial Partners (PNFP), Prosperity Bancshares (PB), F.N.B. Corporation (FNB), IBERIABANK Corporation (IBKC), First Hawaiian (FHB), Hancock Holding Company (HBHC), Texas Capital Bancshares (TCBI), Bank of Hawaii Corporation (BOH), Home BancShares (HOMB), UMB Financial Corporation (UMBF), Associated Banc-Corp (ASB), MB Financial (MBFI) and Chemical Financial Corporation (CHFC).

Zions Bancorporation's management team includes the folowing people:

• Harris Henry Simmons, Chairman of the Board, Chief Executive Officer
• Scott J. McLean, President, Chief Operating Officer, Executive Vice President
• Paul E. Burdiss, Chief Financial Officer, Executive Vice President
• Dianne R. James, Chief Human Resource Officer, Executive Vice President
• Jennifer Smith, Executive Vice President, Chief Information Officer
• Edward P. Schreiber, Executive Vice President, Chief Risk Officer
• Thomas E. Laursen, Executive Vice President, General Counsel, Secretary
• Bruce K. Alexander, Executive Vice President; Chairman, President and Chief Executive Officer of Vectra Bank Colorado
• Aldon Scott Anderson, Executive Vice President; President, Chief Executive Officer of Zions First National Bank
• David E. Blackford, Executive Vice President; Chairman, President, Chief Executive Officer of California Bank & Trust

Zions Bancorporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.51%), State Street Corp (6.12%), American Century Companies Inc. (3.08%), Capital Research Global Investors (2.56%), Thrivent Financial For Lutherans (2.09%) and Dimensional Fund Advisors LP (1.89%). Company insiders that own Zions Bancorporation stock include A Scott Anderson, Alexander Hume, Bruce K Alexander, Dallas E Haun, David E Blackford, Dianne R James, Edward F Murphy, Edward Schreiber, Harris H Simmons, James R Abbott, Joseph L Reilly, Julie G Castle, Keith D Maio, Leeanne B Linderman, Mark Richard Young, Michael Morris, Paul E Burdiss, Shelley Thomas Williams, Stephen D Quinn, Steven Dan Stephens, Thomas E Laursen and W David Hemingway. View Institutional Ownership Trends for Zions Bancorporation.

Zions Bancorporation's stock was sold by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, California Public Employees Retirement System, Dimensional Fund Advisors LP, Fiduciary Management Inc. WI, American Century Companies Inc., Thrivent Financial For Lutherans, First Trust Advisors LP and Systematic Financial Management LP. Company insiders that have sold Zions Bancorporation stock in the last year include Alexander Hume, Bruce K Alexander, David E Blackford, Dianne R James, Edward Schreiber, James R Abbott, Joseph L Reilly, Keith D Maio, Leeanne B Linderman, Mark Richard Young, Michael Morris, Shelley Thomas Williams and Thomas E Laursen. View Insider Buying and Selling for Zions Bancorporation.

Zions Bancorporation's stock was bought by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, Cramer Rosenthal Mcglynn LLC, Janus Henderson Group PLC, Harbour Capital Advisors LLC, State Street Corp, Vanguard Group Inc., Sumitomo Mitsui Trust Holdings Inc. and CI Global Investments Inc.. Company insiders that have bought Zions Bancorporation stock in the last two years include Edward F Murphy, Harris H Simmons, Paul E Burdiss and Stephen D Quinn. View Insider Buying and Selling for Zions Bancorporation.

Shares of Zions Bancorporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Zions Bancorporation stock can currently be purchased for approximately $43.92.